Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation with an Electronic Clinical Decision Support Tool: A Stepped-Wedge Cluster Randomized Trial Design
使用电子临床决策支持工具优化急性心房颤动的中风预防:阶梯楔形集群随机试验设计
基本信息
- 批准号:10415095
- 负责人:
- 金额:$ 29.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdultAffectAmericanAnticoagulantsAnticoagulationArrhythmiaAtrial FibrillationAtrial FlutterCar PhoneCardiovascular systemCaringCase StudyCessation of lifeChronicClient satisfactionClinicClinicalCluster randomized trialComputersDataDevelopmentDiagnosisDiseaseElectronic Health RecordEmergency CareEmergency Department PhysicianEmergency Department evaluationEmergency Department patientEmergency department visitEnvironmentFeedbackFutureGoalsGuideline AdherenceGuidelinesHealthHealth Care CostsHealth systemHealthcare SystemsHeart DiseasesHeart failureHospitalsIncentivesIndividualInterventionKnowledgeManualsMedicareMethodsMissionMonitorMorbidity - disease rateNational Heart, Lung, and Blood InstituteOnline SystemsOralOutcomeOutpatientsPatient CarePatient-Focused OutcomesPatientsPatternPharmaceutical PreparationsPhysiciansPreventionPrimary Health CareProphylactic treatmentProxyResearchResearch PersonnelResource-limited settingResourcesRiskRuralScientistStrokeStroke preventionSystemTestingTimeTrainingUnited StatesUpdateVariantWarfarinacute carebasecare outcomesclinical decision supportclinical decision-makingcomorbiditycomputerized physician order entrycostcost estimatedesignemergency settingsempowermentevidence based guidelinesexperienceheart rhythmhigh riskimplementation toolimprovedmortalityorganizational readinesspatient engagementpatient orientedpatient populationpaymentpreventprimary outcomesecondary outcomeshared decision makingstroke patientstroke risksupport toolstooltrial designweb portal
项目摘要
Abstract Statement
Atrial fibrillation (AF) is the most common arrhythmia in the world, with significant morbidity and mortality. With
appropriate oral anticoagulation, the risk of stroke due to atrial fibrillation decreases by 64%. Although atrial
fibrillation is commonly diagnosed and treated in the Emergency Department (ED), oral anticoagulation is
significantly underprescribed. Underprescribing has been attributed to a lack of empowerment and deferral of
prescribing to longitudinal care clinicians. However, patients often do not follow-up with longitudinal care
clinicians, resulting in missed opportunities to provide guideline-recommended care. Our proposal focuses on
this missed opportunity to change the trajectory of care in the ED for patients with atrial fibrillation with
appropriate early prescribing of oral anticoagulants, and thereby, improve clinical outcomes. This R01
Physician-Scientist Early Investigator proposal is in keeping with the mission of NHLBI "to promote the
prevention and treatment of heart disease … and enhance the health of all individuals so that they can live
longer and more fulfilling lives." We leverage an existing outpatient shared-decision making clinical decision
support tool to improve stroke prevention for patients with atrial fibrillation and test its ability to improve
guideline-recommended care in the acute care setting of the Emergency Department—a fast-paced, episodic,
high-intensity environment. Electronic health record clinical decision support (CDS) tools have emerged as a
means to guide clinicians on best practices and can make a significant impact on clinical outcomes. By
increasing guideline adherence and improving the transition of care from the ED to the outpatient setting, this
proposal could significantly reduce the risk of stroke for patients with atrial fibrillation with an intervention that
could be rapidly and effectively disseminated across other settings. The project is a convergent parallel
quantitative-qualitative study (mixed-methods) consisting of three components: (1) Implement a clinical
decision support tool in a multi-centered stepped-wedge cluster randomized trial, (2) Identify clinician
facilitators and barriers to ideal AF care and refine CDS tools for different settings using qualitative
approaches, and (3) Explore patient satisfaction with the tool for future scalability and generalizability.
This research will allow Dr. Kea to gain knowledge on how the unique environments of each hospital setting
interacts with the CDS tool and how to refine the tool for large-scale dissemination, including rural and
resource-poor environments, on a national scale.
抽象语句
心房颤动(房颤)是世界上最常见的心律失常,发病率和死亡率都很高。使用
适当口服抗凝,房颤引发中风的风险降低%。虽然是心房
纤颤通常在急诊科诊断和治疗,口服抗凝是
严重低估了处方。处方不足被归因于缺乏授权和推迟
给纵向护理临床医生开处方。然而,患者往往不进行纵向护理的随访。
临床医生,导致错过了提供指南建议的护理的机会。我们的建议侧重于
错过了改变急诊室对患有房颤患者的护理轨迹的机会
早期适当的口服抗凝药物,从而改善临床疗效。本R01
医生-科学家早期研究人员提案与NHLBI的使命一致,以促进
预防和治疗心脏病…并增强所有人的健康,以便他们能够
更长和更有成就感的生命。我们利用现有的门诊共享决策临床决策
为房颤患者改善卒中预防并测试其改善能力的支持工具
指南-急诊科急性护理环境中的推荐护理-快节奏、间歇性、
高强度环境。电子健康记录临床决策支持(CDS)工具已经成为一种
对临床医生进行最佳实践指导的手段,并可对临床结果产生重大影响。通过
提高指南的遵从性并改善从急诊科到门诊的护理过渡,这
提案可以显著降低心房颤动患者的中风风险,干预措施
可以在其他环境中迅速有效地传播。这个项目是一个收敛的平行项目。
定量-定性研究(混合方法)由三个部分组成:(1)实施临床
多中心阶梯-楔形群随机试验中的决策支持工具,(2)确定临床医生
理想的房颤护理和完善CDS工具的促进者和障碍
方法,以及(3)探索患者对该工具的满意度,以实现未来的可扩展性和普适性。
这项研究将使Kea博士了解每一家医院的独特环境是如何
与CDS工具互动,以及如何改进该工具以进行大规模传播,包括农村和
资源贫乏的环境,在全国范围内。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bory Kea其他文献
Bory Kea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bory Kea', 18)}}的其他基金
Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation with an Electronic Clinical Decision Support Tool: A Stepped-Wedge Cluster Randomized Trial Design
使用电子临床决策支持工具优化急性心房颤动的中风预防:阶梯楔形集群随机试验设计
- 批准号:
10197697 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation with an Electronic Clinical Decision Support Tool: A Stepped-Wedge Cluster Randomized Trial Design
使用电子临床决策支持工具优化急性心房颤动的中风预防:阶梯楔形集群随机试验设计
- 批准号:
10627824 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 29.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 29.7万 - 项目类别:
Standard Grant














{{item.name}}会员




